SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Fotokimyasal olarak sentezlenen altın nanopartikülleri, Boswellic asit ile konjuge edilmiş alfa synüklein agregasyonunu inhibe eder ve fibrilasyon kinetiğini geciktirir.

Photochemically synthesized gold nanoparticles conjugated with Boswellic acid inhibit alpha synuclein aggregation and delay fibrillation kinetics.

Makine çevirisi · Editoryal inceleme bekliyor

Sci Rep · 2025-07-17

DOI: 10.1038/s41598-025-11107-6PMID: 40670563

Open accessresearch-article; Journal ArticleKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Neurodegenerative disorders are characterised by the gradual degeneration and death of neurons in distinct brain regions. In Parkinson's disease (PD), a key pathological hallmark is the aggregation of misfolded α-synuclein (α-Syn) into neurotoxic fibrils. Although natural products such as Boswellic acids (BAs) from Boswellia serrata exhibit therapeutic potential, their clinical application is limited by poor pharmacokinetic properties. To address this, we investigated BAs conjugated to gold nanoparticles (GNPs) to enhance bioavailability and therapeutic potential. Both covalent and noncovalent β-Boswellic acid to GNPs (GNP-BA) conjugates were synthesized and evaluated for their effects on α-Syn fibrillation in vitro. The spherical GNPs (< 32 nm) were successfully characterized via high-resolution transmission electron microscopy (HR-TEM) and field emission scanning electron microscopy (FESEM). Conjugation of BA was confirmed by UV-Visible and Fourier-transform infrared (FTIR) spectroscopies. Thioflavin T (ThT) assay and atomic force microscopy (AFM) analyses demonstrated that noncovalently bound GNP-BAs significantly inhibited α-Syn fibril formation. Our findings reveal that both synthesis and conjugation strategies significantly influence the anti-aggregation behaviour of GNPs. Notably, photochemically synthesised GNP-BAs exhibited superior biofunctionality. This work introduces a dual-functional nanoplatform that enhances BA bioavailability while effectively inhibiting α-Syn aggregation, offering translational potential for real-world therapeutic development in PD and related synucleinopathies.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.